Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
AstraZeneca
AstraZeneca
Merck Sharp & Dohme LLC
Zhejiang Cancer Hospital
Novo Nordisk A/S
Canadian Cancer Trials Group
Yonsei University
Institut du Cancer de Montpellier - Val d'Aurelle
Guangxi Medical University
Guangxi Medical University
New Mexico Cancer Research Alliance
UNICANCER
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
e-Therapeutics PLC
Massachusetts General Hospital
Stanford University
National Institutes of Health Clinical Center (CC)
Mahidol University
Shanghai Jiao Tong University School of Medicine
Combined Military Hospital, Pakistan